Analysts expect Lyell Immunopharma, Inc. to report revenue of 4,756.58 for Q2 26, against a range of 4,446.57 to 5,066.59. The most recent reported quarter, Q1 26, came in at 2,000.00, a 30.2% miss against the 2,866.34 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 13,000.00 | 34,000.00 | 11,000.00 | 7,000.00 | 8,000.00 | 15,000.00 | 6,000.00 | 2,000.00 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 3,364.05 | 0.00 | 0.00 | 0.00 | 3,962.73 | 0.00 | 15,815.82 | 3,145.55 | 5,066.59 | 4,686.38 | 3,707.51 | 7,497.84 | 16,637.63 | 23,028.65 | 12,662.04 | 20,774.45 | |||||||||||
| Low Estimate | 2,768.67 | 0.00 | 0.00 | 0.00 | 3,674.43 | 0.00 | 13,067.22 | 2,587.13 | 4,446.57 | 4,175.02 | 3,339.81 | 6,586.40 | 15,345.45 | 19,660.13 | 10,992.68 | 18,585.01 | |||||||||||
| Consensus Estimate | 3,066.36 | 0.00 | 0.00 | 0.00 | 3,818.58 | 0.00 | 14,441.52 | 2,866.34 | 4,756.58 | 4,430.70 | 3,523.66 | 7,042.12 | 15,991.54 | 21,344.39 | 11,827.36 | 19,679.73 |
Analysts expect Lyell Immunopharma, Inc. to report earnings per share of -2.09 for Q2 26, against a range of -2.19 to -1.99. The most recent reported quarter, Q1 26, came in at -1.10, a 18.5% beat against the -1.35 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -3.60 | -3.40 | -8.90 | -1.86 | -2.89 | -2.13 | -6.85 | -1.10 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -3.76 | -3.62 | -3.20 | -3.57 | -3.42 | -2.61 | -2.19 | -1.27 | -1.99 | -2.04 | -2.18 | -1.95 | -2.25 | -1.90 | -2.58 | -0.58 | |||||||||||
| Low Estimate | -4.34 | -4.38 | -3.76 | -4.01 | -3.94 | -2.97 | -2.39 | -1.43 | -2.19 | -2.40 | -2.54 | -2.11 | -2.61 | -2.16 | -2.96 | -0.64 | |||||||||||
| Consensus Estimate | -4.05 | -4.00 | -3.48 | -3.79 | -3.68 | -2.79 | -2.29 | -1.35 | -2.09 | -2.22 | -2.36 | -2.03 | -2.43 | -2.03 | -2.77 | -0.61 |